Imunon, Inc. — Director's Dealing 2010

Feb 23, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2010-02-19

Reporting Person: Borys Nicholas (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-02-19	Common Stock (Bonus Grant)	A	7537	$2.94	Acquired	26537	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-02-19	Common Stock Option	$2.94	A	40000	Acquired	2020-02-19	Celsion Common Stock (40000)	Direct

Footnotes

F1: Stock Grant awarded in lieu of cash bonus

F2: Fair value on date of grant award

F3: Options vest 1/3 each on February 19, 2011, 2012 and 2013.